XALATAN is not recommended in patients with a known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product.
XALATAN may slowly cause darkening of the eye color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes may increase as long as XALATAN is administered, and eye color changes are likely to be permanent.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
XALATAN contains benzalkonium chloride, which may be absorbed by contact lenses. Contact lenses should be removed prior to the administration of XALATAN. Contact lenses can be reinserted 15 minutes following administration of XALATAN.
If more than one topical eye medication is used, the drugs should be administered at least five minutes apart.
The most common side effects for XALATAN may include blurred vision, burning and stinging, eye redness, eye itching, the feeling of something in the eye, increased darkening of eye color, or irritation of the clear front surface of the eye.
INDICATION
XALATAN is a prescription medication for the treatment of high eye pressure
/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Please see